Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker

Stroke

Volumn 30, Issue 2, 1999, Pages 433-440

  Seki, Yukio ^b   Feustel, Paul J ^a   Keller Jr , Richard W ^a   Tranmer, Bruce I ^a   Kimelberg, Harold K ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Astrocytes; Biological transport; Cerebral ischemia; Excitatory amino acids; Rats

Indexed keywords

4,4' DINITRO 2,2' STILBENEDISULFONIC ACID; ASPARTIC ACID; CARRIER PROTEIN; GLUTAMIC ACID; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CONTROLLED STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032957182     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.2.433     Document Type: Article

References (40)

1. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol. 1986;19:105-111.
2. Gill R, Foster AC, Woodruff GN. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J Neurosci. 1987;7:3343-3349.
3. Pulsinelli W, Sarokin A, Buchan A. Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia. Prog Brain Res. 1993;96:125-135.
4. Drejer J, Benveniste H, Diemer NH, Schousboe A. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J Neurochem. 1985;45:145-151.
5. Wahl F, Obrenovitch TP, Hardy AM, Plotkine M, Boulu R, Symon L. Extracellular glutamate during focal cerebral ischemia in rats: time course and calcium dependency. J Neurochem. 1994;63:1003-1011.
6. Massieu L, Morales-Villagrán A, Tapia R. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J Neurochem. 1995;64: 2262-2272.
7. Nicholls D, Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol Sci. 1990;11:462-468.
8. Mitani A, Andou Y, Matsuda S, Arai T, Sakanaka M, Kataoka K. Origin of ischemia-induced glutamate efflux in the CA1 field of the gerbil hippocampus: an in vivo brain microdialysis study. J Neurochem. 1994; 63:2152-2164.
9. Szatkowski M, Attwell D. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci. 1994;17:359-365.
10. 3H]-D-aspartate from primary astrocyte cultures in response to raised external potassium. J Neurosci. 1996;16:7803-7811.
11. Phillis JW, Smith-Barbour M, Perkins LM, O'Regan MH. Characterization of glutamate, aspartate, and GABA release from ischemic rat cerebral cortex. Brain Res Bull. 1994;34:457-466.
12. Phillis JW, Song D, O'Regan MH. Inhibition by anion channel blockers of ischemia-evoked release of excitotoxic and other amino acids from rat cerebral cortex. Brain Res. 1997;758:9-16.
13. Busto R, Dietrich WD, Globus MY-T, Valdes I, Scheinberg P, Ginsberg MD. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab. 1987;7:729-738.
14. Ullrich N, Sontheimer H. Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells. Am J Physiol. 1996;270:C1511-C1521.
15. Spink DC, Swann JW, Snead OC, Waniewski RA, Martin DL. Analysis of aspartate and glutamate in human cerebrospinal fluid by high performance liquid chromatography with automated precolumn derivatization. Ann Biochem. 1986;158:79-86.
16. Feustel PJ, Stafford MJ, Allen JS, Severinghaus JW. Ventrolateral medullary surface blood flow determined by hydrogen clearance. J Appl Physiol. 1984;56:150-154.
17. 2 delivery from experimental data: sensitivity to error. J Appl Physiol. 1988;64: 2074-2082.
18. Pasantes-Morales H, Murray RA, Sánchez-Olea R, Morán J. Regulatory volume decrease in cultured astrocytes, II: permeability pathway to amino acids and polyols. Am J Physiol. 1994;266:C172-C178.
19. Roy G. Amino acid current through anion channels in cultured human glial cells. J Membr Biol. 1995;147:35-44.
20. Strange K, Emma F, Jackson PS. Cellular and molecular physiology of volume-sensitive anion channels. Am J Physiol. 1996;270:C711-C730.
21. Ogata T, Nakamura Y, Tsuju K, Shibata T, Kataoka K. A possible mechanism for the hypoxia-hypoglycemia-induced release of excitatory amino acids from cultured hippocampal astrocytes. Neurochem Res. 1995;20:737-743.
22. Kanai Y, Smith CP, Hediger MA. The elusive transporters with a high affinity for glutamate. Trends Neurosci. 1993;16:365-370.
23. Munoz MD, Herreras O, Herranz AS, Solis JM, del Río RM, Lerma J. Effects of dihydrokainic acid of extracellular amino acids and neuronal excitability in the in vivo rat hippocampus. Neuropharmacology. 1987; 26:1-8.
24. Furuta A, Rothstein JD, Martin LJ. Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J Neurosci. 1997;7:8363-8375.
25. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 1996;16:675-686.
26. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG. Functional comparisons of three glutamate transporter subtypes cloned from human cortex. J Neurosci. 1994;14:5559-5569.
27. Yamashita H, Kawakami H, Zhang Y, Hagiwara T, Tanaka K, Nakamura S. Inhibition by folded isomers of L-2-(carboxycyclopropyl)glycine of glutamate uptake via the human glutamate transporter hGluT-1. Eur J Pharmacol Mol Pharmacol. 1995;289:387-390.
28. Pines G, Danbolt NC, Bjørås M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E, Kanner BI. Cloning and expression of a rat brain L-glutamate transporter. Nature. 1992;360:464-467.
29. Obrenovich T, Zilkha E, Urenjak J. Effects of pharmacologic inhibition of glutamate-uptake on ischemia-induced glutamate efflux and anoxic depolarization. Naunyn Schmiedebergs Arch Pharmacol. 1998;357:225-231.
30. Ottersen OP, Laake JH, Reichelt W, Haug FM, Torp R. Ischemic disruption of glutamate homeostasis in brain: quantitative immunocytochemical analyses. J Chem Neuroanat. 1996;12:1-14.
31. Schousboe A, Westergaard N, Waagepetersen HS, Larssson OM, Bakken IJ, Sonnewald U. Trafficking between glia and neurons of TCA cycle intermediates and related metabolites. Glia. 1997;21:99-105.
32. Kimelberg HK. Current concepts of brain edema. J Neurosurg. 1995;83: 1051-1059.
33. + medium causes inhibition of glutamate and aspartate uptake and increases their release. J Cereb Blood Flow Metab. 1995;15:409-416.
34. Solís JM, Herranz AS, Herreras O, Lerma J, del Río RM. Does taurine act as an osmoregulatory substance in the rat brain? Neurosci Lett. 1988;91: 53-58.
35. Wade JV, Olson JP, Samson FE, Nelson SR, Pazdernik TL. A possible role for taurine in osmoregulation within the brain. J Neurochem. 1988; 51:740-745.
36. 3H]aspartate release from primary astrocyte cultures. Am J Physiol. 1998;274:C1511-C1520.
37. - transport in cultured astrocytes. Neurosci Lett. 1993;156:141-144.
38. Singh AK, Afink GB, Venglarik CJ, Wang R, Bridges RJ. Colonic Cl channel blockade by three classes of compounds. Am J Physiol. 1991; 260:C51-C63.
39. Waniewski RA, Martin DL. Characterization of L-glutamic acid transport by glioma cells in culture: evidence for sodium-independent, chloride-dependent high affinity influx. J Neurosci. 1984;4:2237-2246.
40. Barron KD, Dentinger MP, Kimelberg HK, Nelson LR, Bourke RS, Keegan S, Mankes EJ, Cragoe EJ. Ultrastructural features of a brain injury model in cat, I: vascular and neuroglial changes and the prevention of astroglial swelling by a fluorenyl (arloxy) alkanoic acid derivative (L-644-711). Acta Neuropathol (Berl). 1988;75:295-307.